{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "A study on roflumilast, a PDE4 inhibitor used only for chronic obstructive pulmonary disease, in a randomized, double-blind, placebo controlled multicenter study found lowered glucose levels after 12 weeks of treatment in DM patients [XREF_BIBR].",
  "reading_complete" : "2020-07-28T17:07:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:01:17Z",
  "trigger" : "levels",
  "evidence" : [ "glucose levels" ],
  "pmc_id" : "7211212",
  "score" : 0
}